← Back to patent-cliff list
度他雄胺/盐酸坦洛新
Tier C — Watch / tradeDutasteride/Tamsulosin Hydrochloride
韩美药品株式会社
Originator
2010
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：SRD5A、ADRA1A
Brand：Jalyn
Indications (approved)：前列腺增生
Regional status
US
批准上市
2010-06-14
EU
批准上市
2010-06-14
China
临床一期
2024-04-10
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Dutasteride/Tamsulosin Hydrochloride?
Approved indications include: 前列腺增生.
When does the Dutasteride/Tamsulosin Hydrochloride patent expire?
No public expiry year is available for Dutasteride/Tamsulosin Hydrochloride yet; this page updates once verified.
How do I get a quote for Dutasteride/Tamsulosin Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24